Dec 14, 2022 / 01:00PM GMT
Bruce N. Jacobs - Kymera Therapeutics, Inc. - CFO
First, I would like to thank everyone for joining us this morning at this busy time as we approach the holidays. We very much appreciate you taking the time to be here for this update, which we're excited to share with you all. As you have noticed by now, we're using a different format for this call, making use of the video cameras to which you all have been accustomed. I'm here in 1 of the conference rooms in the Kymera offices in Watertown, and Nello and Jared are in their respective offices here at Kymera as well.
After some prepared remarks from Nello and Jared, they will join me here in this room, and we'll turn the call over to questions from our covering analysts. We will be sharing a slide deck on this call. We plan to post that to our website after we wrap our presentation, which we plan to conclude by around 9:30 AM, and the 3 of us will also be available throughout the day for follow up.
At this time, before we get started, I'd like to just remind everyone of our forward-looking statement language. The comments that management
Kymera Therapeutics Inc Investor Webcast KT-474 Clinical Update Call Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers